Complex Subtype Diversity of HIV-1 Among Drug Users in Major Kenyan Cities

AIDS Res Hum Retroviruses. 2017 May;33(5):500-510. doi: 10.1089/AID.2016.0321. Epub 2017 Mar 1.

Abstract

Drug users are increasingly recognized as a key population driving human immunodeficiency virus (HIV) spread in sub-Saharan Africa. To determine HIV-1 subtypes circulating in this population group and explore possible geographic differences, we analyzed HIV-1 sequences among drug users from Nairobi, Mombasa, and Kisumu in Kenya. We sequenced gag and env from 55 drug users. Subtype analysis from 220 gag clonal sequences from 54 of 55 participants (median = 4/participant) showed that 44.4% were A, 16.7% were C, 3.7% were D, and 35.2% were intersubtype recombinants. Of 156 env clonal sequences from 48 of 55 subjects (median = 3/participant), 45.8% were subtype A, 14.6% were C, 6.3% were D, and 33.3% were recombinants. Comparative analysis of both genes showed that 30 (63.8%) participants had concordant subtypes, while 17 (36.2%) were discordant. We identified one genetically linked transmission pair and two cases of dual infection. These data are indicative of extensive HIV-1 intersubtype recombination in Kenya and suggest decline in subtype D prevalence.

Keywords: HIV-1 subtypes; Kenya; drug users; intersubtype recombinants.

MeSH terms

  • Adolescent
  • Adult
  • Cities / epidemiology
  • Coinfection / virology
  • Cross-Sectional Studies
  • Disease Transmission, Infectious
  • Drug Users*
  • Female
  • Genetic Variation*
  • Genotype*
  • HIV Infections / epidemiology
  • HIV Infections / transmission
  • HIV Infections / virology*
  • HIV-1 / classification*
  • HIV-1 / genetics*
  • HIV-1 / isolation & purification
  • Humans
  • Kenya / epidemiology
  • Male
  • Molecular Epidemiology
  • Sequence Analysis, DNA
  • Substance-Related Disorders / complications*
  • Young Adult
  • env Gene Products, Human Immunodeficiency Virus / genetics
  • gag Gene Products, Human Immunodeficiency Virus / genetics

Substances

  • env Gene Products, Human Immunodeficiency Virus
  • gag Gene Products, Human Immunodeficiency Virus